Home » Topics » Regulatory

Regulatory
RSS

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

RPR files for U.S. approval of CFC-free asthma inhalater

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

Dermagraft-TC cleared for marketing

March 20, 1997

Tretinoin gel launched in the U.S.

March 19, 1997

Roberts' Agrylin approved by FDA

March 18, 1997

ProCyte's hair transplant wound dressing approved by FDA

March 17, 1997

FDA approves Viracept for adult and pediatric use

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

First approval for naratriptan

March 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.